The city of Scottsdale, Arizona, currently has 3 active clinical trials seeking participants for COVID19 research studies.
Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS
Recruiting
This is a prospective, phase 3, multicenter, double-blind, randomized placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics (PK) of repeat doses of IgPro20 in participants with post SARS-CoV-2 infection 2019 postural orthostatic tachycardia syndrome (post-Coronavirus Disease 2019 \[COVID-19\] POTS \[post-COVID-POTS\]).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/19/2025
Locations: Mayo Clinic Arizona, Scottsdale, Arizona
Conditions: Post-COVID Postural Orthostatic Tachycardia Syndrome
Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
Recruiting
This study aims to assess the effects of both acute and chronic exposures to hypoxia and hypercapnia in patients with Long COVID syndrome.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/25/2024
Locations: Mayo Clinic in Arizona, Scottsdale, Arizona
Conditions: Long COVID
ARrest RESpiraTory Failure From PNEUMONIA
Recruiting
This research study seeks to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/10/2024
Locations: Mayo Clinic - Scottsdale, Scottsdale, Arizona
Conditions: Pneumonia, Hypoxemia, Acute Respiratory Failure, COVID-19 Pneumonia